• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?

作者信息

van Hooff M H

机构信息

Free University Hospital, Division of Reproductive Endocrinology and Fertility, Amsterdam, The Netherlands.

出版信息

J Assist Reprod Genet. 1995 Apr;12(4):233-5. doi: 10.1007/BF02212923.

DOI:10.1007/BF02212923
PMID:7580017
Abstract
摘要

相似文献

1
The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?
J Assist Reprod Genet. 1995 Apr;12(4):233-5. doi: 10.1007/BF02212923.
2
Ovarian response of individuals to different doses of human menopausal gonadotropin.
Fertil Steril. 1988 Jun;49(6):997-1001.
3
Ovarian stimulation for in-vitro fertilization: clomiphene and HMG.用于体外受精的卵巢刺激：克罗米芬和人绝经期促性腺激素
Hum Reprod. 1988 Oct;3 Suppl 2:11-21. doi: 10.1093/humrep/3.suppl_2.11.
4
Modified natural cycle for in vitro fertilization and embryo transfer in normal ovarian responders.正常卵巢反应者体外受精与胚胎移植的改良自然周期
J Int Med Res. 2010;38(6):2070-6. doi: 10.1177/147323001003800622.
5
Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.以人绝经期促性腺激素进行卵巢储备功能检测作为体外受精结局的预测指标
J Assist Reprod Genet. 2000 Jan;17(1):13-9. doi: 10.1023/a:1009441812247.
6
Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives.口服避孕药抑制后卵巢对人绝经期促性腺激素的反应。
Fertil Steril. 1988 Sep;50(3):516-8.
7
Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.
J Assist Reprod Genet. 1995 Apr;12(4):235-8. doi: 10.1007/BF02212924.
8
A randomized prospective cross-over study of highly purified follicle-stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years.一项关于高纯度促卵泡生成素和人绝经期促性腺激素用于37 - 41岁女性卵巢过度刺激的随机前瞻性交叉研究。
J Assist Reprod Genet. 2000 Feb;17(2):107-12. doi: 10.1023/a:1009418017662.
9
Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.人绝经期促性腺激素和促卵泡生成素与促性腺激素释放激素激动剂脱敏用于体外受精中控制性卵巢过度刺激的比较。
Zhonghua Yi Xue Za Zhi (Taipei). 1995 Jun;55(6):452-6.
10
Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.高纯度人绝经期促性腺激素与重组促卵泡激素在首次体外受精-卵胞浆内单精子注射患者中的有效性比较
Fertil Steril. 2008 Jun;89(6):1685-93. doi: 10.1016/j.fertnstert.2007.05.039. Epub 2007 Aug 6.

引用本文的文献

1
The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer.血清雌二醇水平与克罗米芬/人绝经期促性腺激素卵巢刺激用于体外受精和胚胎移植结局的相关性
Reprod Biol Endocrinol. 2015 Oct 6;13:114. doi: 10.1186/s12958-015-0109-x.

本文引用的文献

1
Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study.
Hum Reprod. 1993 Mar;8(3):369-73. doi: 10.1093/oxfordjournals.humrep.a138053.
2
The FSH threshold concept in clinical ovulation induction.临床促排卵中的促卵泡生成素阈值概念。
Baillieres Clin Obstet Gynaecol. 1993 Jun;7(2):297-308. doi: 10.1016/s0950-3552(05)80132-4.
3
High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer.
Fertil Steril. 1994 Jun;61(6):1058-64. doi: 10.1016/s0015-0282(16)56756-9.
4
An increased initial follicle-stimulating hormone/luteinizing hormone ratio does not affect ovarian responses and the outcomes of in vitro fertilization.
Fertil Steril. 1988 Nov;50(5):777-81. doi: 10.1016/s0015-0282(16)60315-1.
5
Ovarian response of individuals to different doses of human menopausal gonadotropin.
Fertil Steril. 1988 Jun;49(6):997-1001.
6
Lower doses of human menopausal gonadotropin are associated with improved success with in vitro fertilization in women with low body weight.较低剂量的人绝经期促性腺激素与低体重女性体外受精成功率的提高相关。
Am J Obstet Gynecol. 1988 Jan;158(1):64-5. doi: 10.1016/0002-9378(88)90778-8.
7
Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program.
Fertil Steril. 1987 Dec;48(6):964-8. doi: 10.1016/s0015-0282(16)59592-2.
8
Increased human menopausal gonadotropin dose during the early follicular phase: effect on follicular recruitment and treatment outcome.
J In Vitro Fert Embryo Transf. 1989 Apr;6(2):112-7. doi: 10.1007/BF01130738.
9
The predictive value and the management of cycles with low initial estradiol levels.初始雌二醇水平较低周期的预测价值及管理
Fertil Steril. 1990 Jun;53(6):1064-7.
10
High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients.在月经周期开始时进行高剂量促卵泡激素刺激并不能改善低反应患者的体外受精结局。
Fertil Steril. 1990 Mar;53(3):486-9. doi: 10.1016/s0015-0282(16)53345-7.